Trinity Biotech PLC
TRIB- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- SEC CIK
- 0000888721
No open-market purchases or sales by Trinity Biotech PLC insiders were filed in the last 90 days; 20 institutions reported holding it in 13F filings for Q2 2026, worth $379.5K in total; no superinvestor holds it.
Q4 2025 vs. Q3 2025
How the institutions holding Trinity Biotech PLC changed between Q3 2025 and Q4 2025.
All holders in Q4 2025All holders in Q3 2025
| Measure | Q3 2025 | Q4 2025 | Change |
|---|---|---|---|
| Holders | 28 | 27 | −1 |
| Shares | 2.70M | 849.8K | −1.85M (−68.5%) |
| Value | $2.81M | $673.3K | −$2.13M (−76.0%) |
New holders (6)
Institutions that held Trinity Biotech PLC at the end of Q4 2025 but not at the end of Q3 2025.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 14,249 | $11.3K | 0.00% |
| LPL Financial LLC | 12,685 | $10.0K | 0.00% |
| Royal Bank of Canada | 1,000 | $1.00K | 0.00% |
| National Bank of Canada | 1,000 | $791 | 0.00% |
| Triumph Capital Management | 1,000 | $791 | 0.00% |
| FMR LLC | 11 | $9 | 0.00% |
Sold out (7)
Institutions that held Trinity Biotech PLC at the end of Q3 2025 and filed for Q4 2025 without it.
| Institution | Shares, Q3 2025 | Value, Q3 2025 |
|---|---|---|
| Perceptive Advisors LLC | 1,790,000 | $1.86M |
| Citadel Advisors LLC | 39,384 | $41.0K |
| Captrust Financial Advisors | 27,247 | $28.3K |
| Commonwealth Equity Services, LLC | 12,600 | $13.0K |
| Simplex Trading, LLC | 2,257 | $2.00K |
| Northwestern Mutual Wealth Management Co | 25 | $26 |
| GWM Advisors LLC | 3 | $3 |